All In MedTech

FDA Clearance Tracker · P170032

Woven EndoBridge (WEB) Aneurysm Embolization System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Dec 31, 2018 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Dec 31, 2018

Approved

Time to decision

459 days

Received Sep 28, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P170032
Device name
Woven EndoBridge (WEB) Aneurysm Embolization System
Applicant location
Aliso Viejo, CA
Received
Sep 28, 2017
Decided
Dec 31, 2018
Decision
Approved
Supplements
21 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code OPR

FDA's approval statement

As written in FDA's record.

Approval for use in adults to embolize saccular intracranial wide neck bifurcation aneurysms located in the anterior (middle cerebral artery (MCA) bifurcation, internal carotid artery (ICA) terminus, anterior communicating artery (AComm) complex) and posterior (basilar apex) circulations, ranging in size from 3 mm to 10 mm in dome diameter, where the neck size is 4 mm or greater or the dome-to-neck ratio is greater than 1 and less than 2.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code OPR (Intrasaccular Flow Disruption Device).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for MicroVention, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.